Large-Scale Production of 119mTe and 119Sb for Radiopharmaceutical Applications.
Ontology highlight
ABSTRACT: Radionuclides find widespread use in medical technologies for treating and diagnosing disease. Among successful and emerging radiotherapeutics, 119Sb has unique potential in targeted therapeutic applications for low-energy electron-emitting isotopes. Unfortunately, developing 119Sb-based drugs has been slow in comparison to other radionuclides, primarily due to limited accessibility. Herein is a production method that overcomes this challenge and expands the available time for large-scale distribution and use. Our approach exploits high flux and fluence from high-energy proton sources to produce longer lived 119mTe. This parent isotope slowly decays to 119Sb, which in turn provides access to 119Sb for longer time periods (in comparison to direct 119Sb production routes). We contribute the
SUBMITTER: Bennett KT
PROVIDER: S-EPMC6439462 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA